Augmenter of Liver Regeneration Protein Deficiency Promotes Hepatic Steatosis by Inducing Oxidative Stress and MicroRNA-540 Expression
Overview
Affiliations
Levels of augmenter of liver regeneration (ALR), a multifunctional protein, are reduced in steatohepatitis. ALR depletion from ALR /Alb-Cre [ALR-L-knockout (KO)] mouse causes robust steatosis and apoptosis of hepatocytes, and pericellular fibrosis between 1 and 2 wk postbirth. Steatosis regresses by 4 wk upon reappearance of ALR-expressing hepatocytes. We investigated mechanisms of ALR depletion-induced steatosis. ALR-L-KO mice (1-, 2-, and 4 wk old) and Adeno-Cre-transfected ALR hepatocytes were used for in vivo and in vitro studies. ALR depletion from hepatocytes in vivo downregulated peroxisome proliferator-activated receptor (PPAR)-α, carnitine palmitoyl transferase I (CPT1)a, peroxisomal membrane protein 70 (PMP70) (modest down-regulation), and acyl-CoA oxidase 1 (ACOX1). The markedly up-regulated (20X) novel microRNA-540 (miR-540) was identified to target PPARα, PMP70, ACOX1, and CPT1a. ALR depletion from primary hepatocytes increased oxidative stress, miR-540 expression, and steatosis and down-regulated PPARα, ACOX1, PMP70, and CPT1a expression. Anti-miR-540 mitigated ALR depletion-induced steatosis and prevented loss of PPARα, ACOX1, PMP70, and CPT1a expression. Antioxidant N-acetylcysteine and recombinant ALR (rALR) both inhibited ALR depletion-induced miR-540 expression and lipid accumulation in hepatocytes. Finally, treatment of ALR-L-KO mice with rALR between 1 and 2 wk prevented miR-540 expression, and arrested steatosis and fibrosis. We conclude that ALR deficiency-mediated oxidative stress induces generation of miR-540, which promotes steatosis by dysregulating peroxisomal and mitochondrial lipid homeostasis.-Kumar, S., Rani, R., Karns, R., Gandhi, C. R. Augmenter of liver regeneration protein deficiency promotes hepatic steatosis by inducing oxidative stress and microRNA-540 expression.
Wang X, He J, Xie P, Wu Y, Dong L, An W Cell Mol Gastroenterol Hepatol. 2024; 19(3):101436.
PMID: 39647663 PMC: 11786861. DOI: 10.1016/j.jcmgh.2024.101436.
Jouve M, Carpentier R, Kraiem S, Legrand N, Sobolewski C Cancers (Basel). 2023; 15(23).
PMID: 38067261 PMC: 10705678. DOI: 10.3390/cancers15235557.
Nimphy J, Ibrahim S, Dayoub R, Kubitza M, Melter M, Weiss T Int J Mol Sci. 2023; 24(9).
PMID: 37175814 PMC: 10179097. DOI: 10.3390/ijms24098107.
Infante-Menendez J, Gonzalez-Lopez P, Huertas-Larez R, Gomez-Hernandez A, Escribano O Antioxidants (Basel). 2023; 12(2).
PMID: 36829822 PMC: 9952114. DOI: 10.3390/antiox12020262.
Lu Z, Li Y, Li A, Syn W, Wank S, Lopes-Virella M PLoS One. 2022; 17(11):e0277251.
PMID: 36331958 PMC: 9635748. DOI: 10.1371/journal.pone.0277251.